Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NFAT-regulated gene expression after tacrolimus in de novo liver transplant recipients
2018-001290-24Phase 4Completed
- Sponsor
- Medical University of Graz
- Start
- Nov 2018
- Modality
- RNA-Targeting Small Molecules → Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of tacrolimus, sponsored by Medical University of Graz. Primary endpoint: Primary: correlation of NFAT-regulated gene expression with tacrolimus peak level. Started Nov 2018; status: completed.
02
Drugs
tacrolimus
Beyond the preview
Go deeper on 2018-001290-24.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2018-001290-24.